Exciting news in Europe! The CHMP recommends our subcutaneous therapy for patients with advanced #NSCLC with certain EGFR mutations. Read about this potential new option that can improve the treatment experience for patients: bit.ly/3Q0V5OH
03.02.2025 13:19 — 👍 1 🔁 0 💬 1 📌 0
Today, we’re one step closer to transforming care for EGFR-mutated #NSCLC. I’m excited to share that the European Commission has now fully approved our chemotherapy-free regimen—a breakthrough that offers a new way forward for patients and their families across the EU: bit.ly/3E3RBbC
21.01.2025 13:10 — 👍 2 🔁 0 💬 0 📌 0
Proud to share a topline overall survival announcement from the Phase 3 MARIPOSA trial in EGFR-mutated #NSCLC. These data reinforce Johnson and Johnson Innovative Medicine's dedication to help transform what’s possible in cancer care and potentially give patients more time and hope: bit.ly/4a3Dwa9
07.01.2025 13:20 — 👍 10 🔁 2 💬 3 📌 0
Excited to announce the European Commission approved our chemotherapy-free combination therapy for the first-line treatment of EGFRm #NSCLC. Proud to be part of a team at #JNJOncology that continues to drive innovation for patients.
bit.ly/4gz7u8k
30.12.2024 13:27 — 👍 1 🔁 0 💬 0 📌 0
Thanks!
24.11.2024 14:30 — 👍 2 🔁 0 💬 0 📌 0
Medical Oncologist w/ interests in #lungcancer, #sarcoma & #drugdevelopment | Associate Professor, Department of Clinical Oncology & Deputy Medical Director, Phase 1 Clinical Trials Centre, CUHK
Yale MSTP | PGY-2 Osler resident | interested in oncology and Immunogenetics
Deputy Editor at Nature Medicine | Handling & overseeing research in #Oncology #Immunology #Immunotherapy #InfectiousDiseases | Fan of vaccines, 🦖 & democracy | Views all mine
Thoracic oncologist @ClevelandClinic Taussig Cancer Center | Hem/onc graduate @ClevelandClinic | Prior chief resident @UConnIM | Proud husband and father
Lung Cancer Translational Scientist at
Centre Léon Bérard / Cancer Research Center of Lyon (CRCL) 🇨🇴 🇫🇷
Senior Research Director at Private Health Management. Previously, Research Fellow at MSKCC working on cancer genomics and PhD at Penn State University studying cancer evolution.
https://privatehealth.com/
Healthcare comms at Edelman. I'm a dad, BC alum, marathoner, crossworder, theme park nerd, actor & musician. I'm my best when not at rest. He/him
Wife, Mother, Mimi to Benjamin, lover of life, surviving NSCLC, advocate.
Blog: www.theinsightfulbreath.com
International Association for the Study of Lung Cancer
Practicing Hematologist & Oncologist + nerd = me. I break down cancer news and treatments, one Middle-earth metaphor at a time. Join me for facts, laughs, and Gandalf-level wisdom. Stanford ->MSKCC -> IU -> UA -> Kaiser SF -> Intermountain Alta View
Program Director, Cancer Early Detection & Diagnostics #MassGeneralBrigham, mom to boys and beagles, wife, Cornellian Sybil Implementation Consortium, #NoOneDeservesLungCancer, ‘ōlelo Hawai’i, #Equity, #ALCSI, She/her
Early phase drug development and lung oncologist
Reporter, @WTOP. In 2010 was 1st radio reporter using iPhone as main field production device. naugenstein@wtop.com. Stage 4 #lungcancer survivor since 11/2022.
Advancing education, research, and innovation in hematology & oncology. #CancerPrevention #CancerAwareness #CancerSurvivors #CancerCare #HealthEquity #GlobalOncology #GlobalHealth #LGBTQ+🏳️🌈💙
Follow Us: https://buff.ly/MWm1IOU
Associate Director Community Outreach- DEI- 🫁Thoracic Oncology, University of Miami @SylvesterCancer , 🇵🇷Boricua, Co-founder @KidsHelpingKidsSucceed
News and views from the world of clinical oncology and hematology
Stage IV EGFR+ exon 19 lung cancer, dx in 2023 at 37. London, UK
Aspiring advocate!
